Title |
Hallmarks of RET and Co-occuring Genomic Alterations in RET-aberrant CancersHallmarks of RET
|
---|---|
Published in |
Molecular Cancer Therapeutics, September 2021
|
DOI | 10.1158/1535-7163.mct-21-0329 |
Pubmed ID | |
Authors |
Jacob J. Adashek, Aakash P. Desai, Alexander Y. Andreev-Drakhlin, Jason Roszik, Gilbert J. Cote, Vivek Subbiah |
X Demographics
The data shown below were collected from the profiles of 261 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 61 | 23% |
Spain | 11 | 4% |
Brazil | 11 | 4% |
Italy | 9 | 3% |
India | 9 | 3% |
Mexico | 7 | 3% |
France | 7 | 3% |
Colombia | 5 | 2% |
Canada | 5 | 2% |
Other | 35 | 13% |
Unknown | 101 | 39% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 151 | 58% |
Scientists | 56 | 21% |
Practitioners (doctors, other healthcare professionals) | 47 | 18% |
Science communicators (journalists, bloggers, editors) | 6 | 2% |
Unknown | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 25 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 3 | 12% |
Other | 3 | 12% |
Researcher | 2 | 8% |
Student > Bachelor | 1 | 4% |
Professor | 1 | 4% |
Other | 4 | 16% |
Unknown | 11 | 44% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 8 | 32% |
Biochemistry, Genetics and Molecular Biology | 3 | 12% |
Chemistry | 1 | 4% |
Unknown | 13 | 52% |
Attention Score in Context
This research output has an Altmetric Attention Score of 149. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 October 2023.
All research outputs
#282,986
of 25,774,185 outputs
Outputs from Molecular Cancer Therapeutics
#30
of 4,094 outputs
Outputs of similar age
#7,347
of 435,873 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#1
of 52 outputs
Altmetric has tracked 25,774,185 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,094 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,873 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.